Synthetic Cathinones Novel Addictive and Stimulatory Psychoactive Su
Over the last decade a rapidly increasing number of novel psychoactive substance (NPSs), often marketed as “designer drugs”, “legal highs”, “herbal highs”, “research or intermediate chemicals” and “laboratory reagents”, has appeared on the drug market wor
- PDF / 4,429,000 Bytes
- 215 Pages / 453.543 x 683.15 pts Page_size
- 42 Downloads / 185 Views
Jolanta B. Zawilska Editor
Synthetic Cathinones Novel Addictive and Stimulatory Psychoactive Substances
Current Topics in Neurotoxicity Volume 12
Series editors Richard M. Kostrzewa, Johnson City, USA Trevor Archer, Gothenburg, Sweden
Current Topics in Neurotoxicity consists of volumes that cover the latest developments in neurotoxicity studies including neurodegeneration, neuroprotection, and neuroregeneration. The series has a translational focus and addresses the causes of neurotoxicity associated with diseases such as Alzheimers, Parkinsons Disease, autism, HIV associated dementia etc.
More information about this series at http://www.springer.com/series/8791
Jolanta B. Zawilska Editor
Synthetic Cathinones Novel Addictive and Stimulatory Psychoactive Substances
123
Editor Jolanta B. Zawilska Department of Pharmacodynamics Medical University of Łódź Łódź Poland
ISSN 2363-9563 ISSN 2363-9571 (electronic) Current Topics in Neurotoxicity ISBN 978-3-319-78706-0 ISBN 978-3-319-78707-7 (eBook) https://doi.org/10.1007/978-3-319-78707-7 Library of Congress Control Number: 2018936185 © Springer International Publishing AG, part of Springer Nature 2018 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Springer imprint is published by the registered company Springer International Publishing AG part of Springer Nature The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Preface
Over the last decade, a rapidly increasing number of novel psychoactive substance (NPS), often marketed as “designer drugs”, “legal highs”, “herbal highs”, “research or intermediate chemicals”, and “laboratory reagents”, has appeared on the drug market worldwide in an effort to bypass-controlled substance legislation. Products containing those compounds can be purchased online via website distributors, from retail and not-retail v
Data Loading...
